• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸膜间皮瘤的预后因素及炎症指标的预后作用

Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma.

作者信息

Ebinç Senar, Oruç Zeynep, Kalkan Ziya, Karhan Oğur, Urakçı Zuhat, Küçüköner Mehmet, Kaplan Muhammet Ali, Abdurrahman Işıkdoğan

机构信息

Department of Internal Medicine, Division of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakır, Türkiye.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Jan 30;31(1):105-115. doi: 10.5606/tgkdc.dergisi.2023.23365. eCollection 2023 Jan.

DOI:10.5606/tgkdc.dergisi.2023.23365
PMID:36926157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10012989/
Abstract

BACKGROUND

In this study, we aimed to investigate the prognostic factors of malignant pleural mesothelioma and the prognostic value of inflammation indices in malignant pleural mesothelioma.

METHODS

Between January 2002 and December 2019, a total of 132 patients (74 males, 58 females; mean age: 55 years; range, 31 to 79 years) diagnosed with malignant pleural mesothelioma were retrospectively analyzed. Patients" demographic data and laboratory results were recorded. The prognostic value of the following five inflammation indices was evaluated: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, advanced lung cancer inflammation index, C-reactive protein/albumin ratio, and prognostic nutritional index.

RESULTS

Of all patients, 81% (n=107) were aged 65 or older and 61.4% (n=81) had an epithelioid histology. Of 12 variables examined in the multivariate analysis for their relationship with survival, age ≥65 years, non-epithelioid subtype, and prognostic nutritional index <40 were found to be poor prognostic factors. Based on the score constructed from these factors, the good prognostic group (score 0-1) had a median overall survival of 21 months and a one-year survival rate of 77.9%, while the poor prognostic group (score 2-3) had a median overall survival of nine months and a one-year survival rate of 29.7%.

CONCLUSION

Our study results indicate that age ≥65 years, prognostic nutritional index <40, and non-epithelioid histological subtype are poor prognostic factors of malignant pleural mesothelioma.

摘要

背景

在本研究中,我们旨在探讨恶性胸膜间皮瘤的预后因素以及炎症指标在恶性胸膜间皮瘤中的预后价值。

方法

回顾性分析2002年1月至2019年12月期间共132例诊断为恶性胸膜间皮瘤的患者(74例男性,58例女性;平均年龄:55岁;范围31至79岁)。记录患者的人口统计学数据和实验室结果。评估以下五个炎症指标的预后价值:中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、晚期肺癌炎症指数、C反应蛋白/白蛋白比值和预后营养指数。

结果

在所有患者中,81%(n = 107)年龄在65岁及以上,61.4%(n = 81)具有上皮样组织学类型。在多变量分析中检查的1与生存相关的2个变量中,年龄≥65岁、非上皮样亚型和预后营养指数<40被发现是不良预后因素。根据这些因素构建的评分,良好预后组(评分0 - 1)的中位总生存期为21个月,一年生存率为77.9%,而不良预后组(评分2 - 3)的中位总生存期为9个月,一年生存率为29.7%。

结论

我们的研究结果表明,年龄≥65岁、预后营养指数<40和非上皮样组织学亚型是恶性胸膜间皮瘤的不良预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/523709891daf/TJTCS-2023-31-1-105-115-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/95926bc76465/TJTCS-2023-31-1-105-115-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/fe9f256c972b/TJTCS-2023-31-1-105-115-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/177e5c69123f/TJTCS-2023-31-1-105-115-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/523709891daf/TJTCS-2023-31-1-105-115-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/95926bc76465/TJTCS-2023-31-1-105-115-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/fe9f256c972b/TJTCS-2023-31-1-105-115-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/177e5c69123f/TJTCS-2023-31-1-105-115-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f50d/10012989/523709891daf/TJTCS-2023-31-1-105-115-F4.jpg

相似文献

1
Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma.恶性胸膜间皮瘤的预后因素及炎症指标的预后作用
Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Jan 30;31(1):105-115. doi: 10.5606/tgkdc.dergisi.2023.23365. eCollection 2023 Jan.
2
Prognostic impact of inflammation in malignant pleural mesothelioma: A large-scale analysis of consecutive patients.炎症对恶性胸膜间皮瘤的预后影响:对连续患者的大规模分析
Lung Cancer. 2022 Apr;166:221-227. doi: 10.1016/j.lungcan.2022.03.014. Epub 2022 Mar 19.
3
Inflammation-based prognostic indices in malignant pleural mesothelioma.基于炎症的恶性胸膜间皮瘤预后指标。
J Thorac Oncol. 2012 Mar;7(3):587-94. doi: 10.1097/JTO.0b013e31823f45c1.
4
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.Ki67指数是上皮样恶性胸膜间皮瘤而非非上皮样恶性胸膜间皮瘤的独立预后因素:一项多中心研究。
Br J Cancer. 2015 Mar 3;112(5):783-92. doi: 10.1038/bjc.2015.9. Epub 2015 Jan 29.
5
Prognostic values of preoperative C-reactive protein, albumin, and neutrophil ratios in patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy.术前 C 反应蛋白、白蛋白和中性粒细胞比值对接受胸膜外全肺切除术的恶性胸膜间皮瘤患者的预后价值。
Surg Oncol. 2022 Aug;43:101813. doi: 10.1016/j.suronc.2022.101813. Epub 2022 Jul 6.
6
A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.恶性胸膜间皮瘤总生存的一种新预后指数:rPHS(治疗方案、体能状态、组织学或分期)指数
Jpn J Clin Oncol. 2015 Jun;45(6):562-8. doi: 10.1093/jjco/hyv039. Epub 2015 Apr 2.
7
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.新南威尔士州大量恶性胸膜间皮瘤患者生存相关因素
Br J Cancer. 2014 Oct 28;111(9):1860-9. doi: 10.1038/bjc.2014.478. Epub 2014 Sep 4.
8
A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.核分级系统是上皮样弥漫性恶性胸膜间皮瘤生存的有力预测指标。
Mod Pathol. 2012 Feb;25(2):260-71. doi: 10.1038/modpathol.2011.146. Epub 2011 Oct 7.
9
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.不可切除恶性胸膜间皮瘤患者预后因素的当代分析
J Thorac Oncol. 2016 Feb;11(2):249-55. doi: 10.1016/j.jtho.2015.10.003. Epub 2015 Dec 10.
10
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.淋巴细胞与单核细胞比值对恶性胸膜间皮瘤患者的预后意义。
Lung Cancer. 2015 Oct;90(1):111-7. doi: 10.1016/j.lungcan.2015.07.014. Epub 2015 Jul 30.

引用本文的文献

1
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis.全身炎症和临床病理特征对恶性胸膜间皮瘤生存的影响:一项多中心分析
Medicina (Kaunas). 2025 Jan 16;61(1):144. doi: 10.3390/medicina61010144.

本文引用的文献

1
The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography parameters in patients with malignant pleural mesothelioma.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描参数对恶性胸膜间皮瘤患者的预后价值
Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Jan 13;29(1):92-100. doi: 10.5606/tgkdc.dergisi.2021.20432. eCollection 2021 Jan.
2
Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.恶性胸膜间皮瘤的生物标志物——关于炎症的新观点
Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658.
3
Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma.
表皮生长因子受体(EGFR)和磷酸酶及张力蛋白同源物(PTEN)表达以及血小板与淋巴细胞比率(PLR)和中性粒细胞与淋巴细胞比率(NLR)对预测上皮样恶性腹膜间皮瘤预后的意义
Gastroenterol Res Pract. 2019 Feb 4;2019:7103915. doi: 10.1155/2019/7103915. eCollection 2019.
4
The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.C 反应蛋白/白蛋白比值是恶性胸膜间皮瘤患者的一种新的显著预后因素:一项回顾性多机构研究。
Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.
5
Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?高级肺部炎症指数(ALI)在转移性非小细胞肺癌中是否具有预后意义?
Clin Respir J. 2018 Jun;12(6):2013-2019. doi: 10.1111/crj.12768. Epub 2018 Feb 9.
6
Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis.中性粒细胞与淋巴细胞比值在恶性胸膜间皮瘤患者中的预后意义:一项荟萃分析
Oncotarget. 2017 Feb 16;8(34):57460-57469. doi: 10.18632/oncotarget.15404. eCollection 2017 Aug 22.
7
Malignant Mesothelioma Mortality - United States, 1999-2015.美国1999 - 2015年恶性间皮瘤死亡率
MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):214-218. doi: 10.15585/mmwr.mm6608a3.
8
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值作为恶性间皮瘤预后指标是否可靠?
Ther Clin Risk Manag. 2016 Apr 22;12:651-6. doi: 10.2147/TCRM.S104077. eCollection 2016.
9
Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.恶性胸膜间皮瘤患者预后与中性粒细胞:淋巴细胞及血小板:淋巴细胞比值的关系
Asian Pac J Cancer Prev. 2014;15(5):2061-7. doi: 10.7314/apjcp.2014.15.5.2061.
10
Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma.预后营养指数预测恶性胸膜间皮瘤的结局。
J Cancer Res Clin Oncol. 2013 Dec;139(12):2117-23. doi: 10.1007/s00432-013-1523-0. Epub 2013 Oct 23.